AIPPI World Congress
September 10 to 13, 2022
Location
San Francisco, California, USA
Contact
Credits
CLE available, total minutes TBD
Registration
AIPPI, hosted by the US Group of AIPPI, will be coming together in person
again to take part in the making of AIPPI's resolutions. Experts from
different countries and regions will be sharing and exchanging insights
on various areas of IP. 
Exceptional Programme:
- Panel Sessions (incl. Pharma Panels)
- UPC Boot Camp NEW
- AIPPI Cafés
- Women in AIPPI Social Event
- Young Members Forum
- 3 Social Events (incl. Closing Dinner)
IP Lunches (incl. Diversity and Inclusion Today, Would you like some IP with your Wine?, and Copyright in Graffiti and Street Art)
AIPPI offers an Exclusive Limited Package that includes hotel accommodation at an attractive fee.
The package is limited and will be offered on a first-come-first-served basis.
For more information, to view the Study Questions, and to learn about Sponsorship Opportunities: CLICK HERE
CLE will be offered, total amount to be determined.
If you're not currently a member of AIPPI, you can join and register directly through the registration process. If you're already an AIPLA member, but are not a member of AIPPI-US, you can join the group during the renewal process by adding AIPPI-US when you renew. If you're not an AIPLA member, you can join AIPLA and add AIPPI-US through the join process. For more information about membership eligibility please see the Committee webpage here: https://www.aipla.org/committees/aippi-us
News
-
AIPLA Submits Comments on the World Intellectual Property Organization Riyadh Design Law Treaty
June 24, 2026
Alexandria, VA. June 11, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments on the World Intellectual Property Organization Riyadh Design Law Treaty. -
.png?sfvrsn=143e8f56_1 "supreme court")
AIPLA Files Amicus Brief in Arbutus Biopharma Corp. v. Moderna, Inc.
June 22, 2026
Arlington, VA. June 5, 2026 – The American Intellectual Property Law Association (AIPLA) filed an amicus brief in Arbutus Biopharma Corp. v. Modernatx, Inc. -
Supreme Court Issues Unanimous Decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc.
June 4, 2026
On June 4, 2026, the Supreme Court issued a unanimous decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. While the Court reaffirmed existing law on pleading standards, it reversed the Federal Circuit’s decision that had focused on how relevant statements could be understood by medical providers as instructions to infringe. The amicus brief filed by AIPLA on March 27, 2026, advocated for affirmance and cautioned the Court not to change the patent infringement pleading standard or adopt any categorical exemption from inducement for a particular industry. -
AIPLA Views on H.R. 3269, the “ETHIC Act,” and H.R. 6485, the “Skinny Labels, Big Savings Act”
June 3, 2026
Arlington, VA. June 3, 2026 – The American Intellectual Property Law Association (AIPLA) submitted a letter to the House Judiciary Committee’s Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet outlining its views on H.R. 3269, the “ETHIC Act,” and H.R. 6485, the “Skinny Labels, Big Savings Act.” -
AIPLA Submits Comments to the USPTO on 2026 Supplemental GUI Guidance
May 15, 2026
Arlington, VA. May 12, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments to the USPTO on its Supplemental Guidance for Examination of Design Patent Applications Related to Computer-Generated Interfaces and Icons, issued on March 13, 2026.